Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nitric Oxide Signaling Pathway

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Antihypertensive Drugs: Vasodilators

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

Autoregulation of Blood Flow

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cytokine Profiling of Systemic Sclerosis-Related Pulmonary Hypertension.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same author

Many uncertainties remain in the long-term care of sickle cell disease-pulmonary hypertension.

American journal of respiratory and critical care medicine·2026

Same author

Provider networks for pulmonary hypertension in Massachusetts: implications for improving referrals to expert care.

Annals of the American Thoracic Society·2026

Same author

Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain.

Rheumatology (Oxford, England)·2026

Same author

Let's Not Keep Acute Chest Syndrome Under an Umbrella.

American journal of respiratory and critical care medicine·2025

Same author

Contemporary reperfusion therapies in patients with intermediate- and high-risk pulmonary embolism.

Thrombosis research·2025

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Sickle cell anemia and vascular dysfunction: the nitric oxide connection.

Idowu Akinsheye¹, Elizabeth S Klings

¹Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.

Journal of Cellular Physiology

|June 26, 2010

Summary

Sickle cell anemia causes endothelial dysfunction and impairs nitric oxide bioavailability due to hemolysis. This review explores how reduced nitric oxide contributes to pulmonary hypertension in sickle cell disease patients.

More Related Videos

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

Published on: July 21, 2023

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

Related Experiment Videos

Last Updated: Jun 12, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

Published on: July 21, 2023

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

Area of Science:

Cardiovascular Science
Hematology
Pulmonary Medicine

Background:

Sickle cell anemia involves HbS mutation leading to erythrocyte damage and hemolysis.
Hemolysis releases free hemoglobin, scavenging nitric oxide and reducing its bioavailability.
Endothelial dysfunction is a key feature in sickle cell anemia pathogenesis.

Purpose of the Study:

To review mechanisms of altered nitric oxide bioavailability in sickle cell anemia.
To explore the role of impaired nitric oxide in pulmonary hypertension development.
To summarize current understanding of sickle cell anemia and pulmonary hypertension link.

Main Methods:

Literature review of studies on sickle cell anemia, nitric oxide, and pulmonary hypertension.
Analysis of mechanisms linking hemolysis, nitric oxide depletion, and vascular dysfunction.
Synthesis of evidence implicating nitric oxide in pulmonary hypertension pathogenesis.

Main Results:

Intravascular hemolysis in sickle cell anemia significantly reduces nitric oxide bioavailability.
Reduced nitric oxide bioavailability contributes to endothelial dysfunction and vascular changes.
Pulmonary hypertension affects 30-40% of sickle cell anemia patients, linked to hemolysis.

Conclusions:

Impaired nitric oxide bioavailability is a critical factor in sickle cell anemia.
Reduced nitric oxide bioavailability is implicated in the pathogenesis of pulmonary hypertension in sickle cell disease.
Targeting nitric oxide pathways may offer therapeutic strategies for sickle cell-associated pulmonary hypertension.